[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

4

07/16/2025 - 04:30 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

#1816 Ranked by Market Cap

N/A Ranked by Dividends

KNSA Latest News

Aug 28, 2025

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Jul 29, 2025

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

Jul 24, 2025

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

Jun 5, 2025

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

May 29, 2025

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

KNSA Latest SEC Filings

Oct 8, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Oct 1, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Sep 29, 2025

[144] Kiniksa Pharmaceuticals International, plc SEC Filing

Sep 17, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Sep 17, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

KNSA Stock Data

Market Cap 2.82B

Float 41.82M

Insiders Ownership 3.74%

Institutions Ownership 92.97%

Short Percent 3.65%

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country United Kingdom

City LONDON